Annular Closure Device Market Global Report 2026

The annular closure device market size has grown rapidly in recent years. It will grow from $1.02 billion in 2025 to $1.14 billion in 2026 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to rising prevalence of cardiovascular disorders, increasing adoption of surgical heart valve repair procedures, growing elderly population with cardiac conditions, advancements in implant material technologies, increasing awareness regarding early cardiac treatment.

The annular closure device market size is expected to see rapid growth in the next few years. It will grow to $1.7 billion in 2030 at a compound annual growth rate (CAGR) of 10.6%. The growth in the forecast period can be attributed to increasing demand for minimally invasive cardiovascular procedures, growth in transcatheter repair technologies, rising investments in cardiovascular device innovation, increasing focus on personalized treatment approaches, expansion of healthcare infrastructure in emerging markets. Major trends in the forecast period include increasing adoption of minimally invasive valve repair procedures, growing demand for durable and biocompatible implant materials, rising preference for customized annuloplasty repair solutions, increasing use of advanced implant design technologies, expansion of transcatheter valve repair approaches.

The increasing prevalence of spinal disorders is expected to drive the growth of the annular closure device market going forward. Spinal disorders refer to a range of medical conditions that impact the structure, alignment, or functionality of the spine, resulting in pain, limited mobility, or neurological symptoms caused by compression or damage to spinal tissues or nerves. The growing prevalence of spinal disorders is mainly attributed to aging populations, as age-related degeneration of spinal discs, joints, and bones increases susceptibility to conditions such as disc herniation, spinal stenosis, and chronic back pain. An annular closure device helps treat spinal disorders by mechanically closing annular defects following discectomy procedures, restoring disc integrity, and reducing the risk of recurrent disc herniation and associated complications. For instance, in May 2023, according to Spinal Cord Inc., a US-based resource for individuals affected by spinal cord injuries and their families, the United States reported approximately 18,000 new spinal cord injury (SCI) cases in 2023, with an estimated 302,000 people living with SCI across the country. Therefore, the increasing prevalence of spinal disorders is driving the growth of the annular closure device market.

The rising healthcare expenditure is expected to drive the growth of the annular closure device market going forward. Healthcare expenditure refers to the overall financial resources allocated toward medical services, healthcare infrastructure, medications, preventive care, and other healthcare-related activities over a specific period. Healthcare expenditure is increasing due to the growing burden of chronic diseases, which requires prolonged medical treatment, regular hospital visits, advanced diagnostic procedures, and continuous patient management. Increased healthcare spending supports the adoption of annular closure devices by allowing hospitals and healthcare systems to invest in advanced spinal surgery technologies that help reduce recurrent disc herniation risks and avoid expensive revision surgeries, thereby improving long-term patient outcomes. For instance, in April 2025, according to the Office for National Statistics, a UK-based government agency, healthcare spending increased by 6.5% between 2023 and 2024, exceeding the 6.3% growth recorded in 2023. Therefore, the rising healthcare expenditure is driving the growth of the annular closure device market.

Major companies operating in the annular closure device market are focusing on developing advanced solutions, such as bone-anchored annular closure technology, to enhance spinal stability, lower the risk of disc reherniation, and improve recovery outcomes after discectomy procedures. Bone-anchored annular closure technology refers to an advanced spinal repair approach that uses implantable mesh components and vertebral fixation mechanisms to seal annular defects, maintain disc integrity, and prevent recurrent lumbar disc herniation following discectomy. For instance, in March 2026, Intrinsic Therapeutics Inc., a US-based medical device company, launched the Barricaid Narrow Anchor Device, an advanced bone-anchored annular closure technology designed for lumbar discectomy patients with large annular defects. The device aims to improve implantation efficiency, reduce anatomical disruption, and broaden patient eligibility for annular closure procedures. It is specifically designed to lower disc reherniation and reoperation rates following lumbar discectomy procedures.

Major companies operating in the annular closure device market report are Intrinsic Therapeutics Inc., Anchor Orthopedics XT Inc., Medtronic plc, Abbott Laboratories, Teleflex Incorporated, Terumo Medical Corporation, Endocore GmbH.

North America was the dominating region in the annular closure device market in 2025. Asia-Pacific is expected to be the rapidly growing region in the forecast period. The regions covered in the annular closure device market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the annular closure device market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

This product will be delivered within 3-5 business days.